kabutan

Chordia Therapeutics, Dec-Feb (2Q) Ordinary Profit Loss Narrows

Fri Apr 11, 2025 11:30 am JST Earnings

190A Chordia Therapeutics Inc. 【J-GAAP】

Earnings Report

Chordia Therapeutics Inc. <190A> [TSE Growth] announced its financial results at noon (11:30) on April 11th. The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending August 2025 (September 2024 to February 2025) expanded to a loss of 0.97 billion yen (compared to a loss of 0.8 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the March to August period (2H) is expected to expand to a loss of 1.4 billion yen (compared to a loss of 1.02 billion yen in the same period last year).

In the most recent three-month period, from December to February (2Q), the ordinary loss improved to a deficit of 0.36 billion yen (compared to a loss of 0.38 billion yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Sep - Feb, 2024 0 -996 -975 -976 -14.3 ー Apr 11, 2025 J-GAAP
YoY － － － － －

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep - Feb, 2024 Guidance ー ー ー ー － 0 Oct 11, 2024 J-GAAP
Sep - Feb, 2024 Results 0 -996 -975 -976 -14.3 0 Apr 11, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2024 0 -992 -1,023 -1,025 -17.5 0 Oct 11, 2024 J-GAAP
Mar - Aug, 2025 Guidance ー -1,438 -1,403 -1,404 -20.4 0 Apr 11, 2025 J-GAAP
YoY － -45.0% -37.1% -37.0% -16.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug, 2024 0 -1,801 -1,824 -1,827 -31.1 0 Oct 11, 2024 J-GAAP
Aug, 2025 Guidance ー -2,434 -2,378 -2,380 -34.5 0 Oct 11, 2024 J-GAAP
YoY － -35.1% -30.4% -30.3% -10.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Mar - May, 2024 0 -371 -374 -375 -6.7 -Inf Jul 16, 2024 J-GAAP
Jun - Aug, 2024 0 -621 -649 -650 -11.1 -Inf Oct 11, 2024 J-GAAP
Sep - Nov, 2024 0 -624 -615 -616 -9.1 -Inf Jan 14, 2025 J-GAAP
Dec - Feb, 2024 0 -372 -360 -360 -5.3 -Inf Apr 11, 2025 J-GAAP
YoY － － － － －

Related Articles